Journey with Heni
Clinical Research
  • ABOUT
  • CONTACT
  • Newsletter

What is a Contract Research Organization (CRO)?

Contract Research Organization CRO

In clinical research, a Contract Research Organization (CRO) is a company typically hired by a sponsor to manage clinical research sites conducting a trial, ensuring data integrity and patient safety.

Purpose of a CRO:

A CRO acts as the intermediary between the sponsor and the site. They ensure adherence to the study protocol and address protocol deviations, adverse events (AEs), and serious adverse events (SAEs). Clinical Research Associates (CRAs) are available to support site staff and assist with recruitment if the site isn’t meeting goals.

Role of a CRA:

A Clinical Research Associate (CRA), assigned by the CRO, serves as the primary point of contact for the site regarding study-related questions. CRAs also conduct monitoring visits throughout the study timeline to oversee compliance and progress.

Role of a CRA:

A Clinical Trial Manager (CTM) oversees the overall execution of the clinical trial. They manage timelines, budgets, and resources, and ensure that the study runs smoothly across multiple sites. CTMs work closely with CRAs to ensure that trial objectives are met and regulatory requirements are followed.

Electronic Data Capture (EDC):

CROs use Electronic Data Capture (EDC) tools for data collection, randomization, and protocol requirements. Familiarity with the EDC system ensures smooth participant visits. But if you still get stuck, you can always contact the CRA or refer to the provided sources. One of my favorite resources for a quick recap is the SIV slides. Sometimes, the informed consent form also provides some high-level study information that may be useful to the site staff’s comprehension of the study.  

Email Communication:

Maintaining accurate written communication is critical in clinical research. Email correspondence is often saved for future reference. If a conversation occurs over the phone, it is important to follow up with an email summarizing the discussion to ensure accountability. Sites can sometimes be blamed for issues that arise during a study, so adopting habits like these—along with thoroughly understanding the sponsor-provided protocol—can help protect the site and support accurate decision-making when necessary.

→

16 Components of a Study Protocol in Clinical Research 5 Career Progression in the Clinical Research Industry

Related Posts

Primary and Secondary Patents in Pharmaceutical

Clinical Research, Industry-Specific Topics

Primary vs. Secondary Patents in Pharma Industry – What Is the Difference?

In the pharmaceutical industry, primary and secondary patents are two important types of intellectual property (IP) protection that drug companies use to secure their innovations. They serve different purposes and provide varying levels of protection for a drug. “Big Pharma” companies rely on both primary and secondary patents to beat competition in the market. These […]

Composition of Matter Patents in drug development

Clinical Research, Industry-Specific Topics

What Are Composition of Matter Patents in Drug Development?

In the competitive world of pharmaceuticals, protecting innovative drug discoveries is not just a priority—it’s a necessity.This article explores composition of matter patents, a cornerstone of intellectual property protection in drug development, and their role in safeguarding pharmaceutical innovations. Composition of matter patents, also known as primary patents, are a key form of intellectual property […]

Generic competition

Clinical Research, Industry-Specific Topics

Strategies Brand Companies Use to Delay Generic Competition After Patent Expiry

Brand-name pharmaceutical companies often employ various strategies to maintain their market share and delay the entry of generic drugs after the expiration of their patents. These tactics aim to minimize generic competition and protect the brand’s revenue streams, even after their exclusivity rights end from primary patents. These typically focus on leveraging brand loyalty by […]

Subscribe to the newsletter!